A REVIEW ARTICLE ON ANTI-VIRAL AND ANTI-INFLAMMATORY TREATMENTS COVID-19
*Mashirah Rahman, Himanchal Sharma and Muskanbhardwaj
ABSTRACT
The global health and economic systems experienced an extraordinary destabilisation in 2020 as a result of the COVID-19 epidemic. Due of COVID-19's quick spread and potentially fatal effects, it has become necessary to evaluate repurposed medications by looking into treatments already used for other reasons, including antiviral and anti-inflammatory treatment therapy. The global COVID-19 pandemic, which is marked by severe morbidity and mortality, has spread widely. The unchecked inflammatory processes that SARS-CoV-2 infected individuals experienced may be one of the notable dangers connected to death. Since there are no particular medications, it is urgently necessary to employ safe and efficient treatment methods in order to reduce viral damage and alleviate severe inflammation at the same time. Both extreme intense respiratory disorder (SARS) and Covid illness 2019 (Coronavirus) are recognized by an over-the-top provocative reaction; be that as it may, for SARS, the viral burden isn't related with the seriousness of side effects.
[Full Text Article] [Download Certificate]